Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia

NCT00315484 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

358

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Chemotherapy

Interventions

DRUG: Epoetin alfa and Darbepoetin alfa

Sponsor

Ortho Biotech Products, L.P.